Guanchiale, L. “Small Molecules for the Treatment of CLL. Second Generation BTK Inhibitors: Acalabrutinib”. Journal of Hematology 22, no. 1 (April 17, 2019): 81–85. Accessed November 12, 2026. https://www.revistahematologia.com.ar/index.php/Revista/article/view/115.